Libbey N P, Chazan J A, London M R, Pono L, Abuelo J G
Department of Pathology, Roger Williams Medical Center, Providence, RI 02908.
Clin Nephrol. 1993 Apr;39(4):214-23.
We examined bone biopsies from 47 patients on chronic hemodialysis, and analyzed the histomorphometric and biochemical findings and histologic quantitation of bone aluminium, looking primarily at mineralization lag time (Mlt) to evaluate its usefulness in categorization of renal osteodystrophy (ROD). The patients were categorized as having either relatively normal Mlt (< 35 days, n = 21 patients), moderately prolonged Mlt (35-100 days, n = 13 patients) or markedly prolonged Mlt (> 100 days, n = 13 patients). The group with relatively normal Mlt showed significantly higher C-terminal parathyroid hormone (PTHc) levels (26,141 +/- 19,270 vs 7,226 +/- 6,073 and 4,434 +/- 4,000 pg/ml) than the moderately or markedly prolonged Mlt groups (p < .01) and was associated with histologic characteristics of osteitis fibrosa or mild hyperparathyroidism (BFR/BS range 0.146-0.947 mcm3/mcm2/d). The group with markedly prolonged Mlt included one patient with classic and 11 with adynamic osteomalacia (BFR/BS range 0.009-0.099) and had greater bone aluminum (Al.S/OS 35.3 +/- 26.7% vs 7.2 +/- 9.0%) than the normal Mlt group (p < .01). The group with moderately prolonged Mlt included two patients with aplastic bone disease (Mlt 80.0 and 84.6 days, and Al.S/OS 100.0 and 72.3%) and 11 patients with features of hyperparathyroidism and osteomalacia (BFR/BS range 0.068-0.243) with variable but generally intermediate bone aluminum deposition (Al.S/OS 22.5 +/- 19.9%). Like BFR/BS and other dynamic parameters Mlt correlates with morphologic types of ROD which primarily reflect bone turnover, but it may also suggest varying degrees of mineralization impairment in a spectrum ranging from high to low turnover types of ROD. Its usefulness in this respect should not be overlooked.
我们检查了47例慢性血液透析患者的骨活检标本,分析了骨组织形态计量学、生化指标及骨铝的组织学定量结果,主要观察矿化延迟时间(Mlt),以评估其在肾性骨营养不良(ROD)分类中的作用。将患者分为Mlt相对正常(<35天,n = 21例)、Mlt中度延长(35 - 100天,n = 13例)或Mlt显著延长(>100天,n = 13例)三组。Mlt相对正常组的C末端甲状旁腺激素(PTHc)水平显著高于Mlt中度延长组或显著延长组(26,141±19,270 vs 7,226±6,073和4,434±4,000 pg/ml,p <.01),且与纤维性骨炎或轻度甲状旁腺功能亢进的组织学特征相关(骨形成率/骨表面积范围为0.146 - 0.947 mcm³/mcm²/d)。Mlt显著延长组包括1例典型动力缺失性骨软化症患者和11例动力缺失性骨软化症患者(骨形成率/骨表面积范围为0.009 - 0.099),其骨铝含量高于Mlt正常组(铝表面积/骨表面积为35.3±26.7% vs 7.2±9.0%,p <.01)。Mlt中度延长组包括2例再生障碍性骨病患者(Mlt分别为80.0天和84.6天,铝表面积/骨表面积分别为100.0%和72.3%)以及11例具有甲状旁腺功能亢进和骨软化症特征的患者(骨形成率/骨表面积范围为0.068 - 0.243),骨铝沉积量可变但一般处于中等水平(铝表面积/骨表面积为22.5±19.9%)。与骨形成率/骨表面积及其他动态参数一样,Mlt与主要反映骨转换的ROD形态学类型相关,但它也可能提示从高转换型到低转换型ROD范围内不同程度的矿化受损。其在这方面的作用不应被忽视。